Simultaneous gene editing and haploid induction

US10519456B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10519456-B2
Application numberUS-201916245923-A
CountryUS
Kind codeB2
Filing dateJan 11, 2019
Priority dateDec 2, 2016
Publication dateDec 31, 2019
Grant dateDec 31, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The presently disclosed subject matter relates to using a haploid inducing line (whether existing or created) and transforming the haploid line so that it encodes cellular machinery capable of editing genes. The transformed haploid inducing line is used as a parent in a cross between two plants. During pollination, the parental gametes fuse to form an embryo; and the gene editing machinery is also delivered to the embryo at this time. During embryonic development, one set of parental chromosomes are lost, and the gene editing machinery operates on the remaining set of chromosomes. Thus, at least one haploid progeny with edited genes is produced from the cross.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of editing dicot genomic DNA, comprising: a) obtaining a first dicot plant comprising a mutation in a centromeric histone 3 (CENH3) gene and optionally a maize CENH3 tailswap transgene, wherein said first dicot plant expresses a DNA modification enzyme and optionally at least one guide nucleic acid; b) obtaining a second dicot plant, wherein the second dicot plant comprises the dicot plant genomic DNA which is to be edited; c) pollinating the first dicot plant with pollen from the second dicot plant; and d) selecting at least one haploid progeny produced by the pollination of step (c) wherein the haploid progeny comprises the genome of the second dicot plant but not the first dicot plant, and the genome of the haploid progeny has been modified by the DNA modification enzyme and optional at least one guide nucleic acid delivered by the first dicot plant; wherein the mutation in a CENH3 gene is selected from the group consisting of a loss-of-function mutation, a partial loss-of-function mutation, a restored frameshift mutation, and an in-frame deletion mutation. 2. The method of claim 1 further comprising: e) allowing the at least one haploid progeny selected in step (d) to undergo chromosome doubling. 3. The method of claim 2 , wherein the edited haploid progeny undergoes spontaneous chromosome doubling, thereby creating an edited doubled haploid progeny. 4. The method of claim 2 , wherein the edited haploid progeny is treated with a chromosome doubling agent, thereby creating an edited doubled haploid progeny. 5. The method of claim 4 , wherein the chromosome doubling agent is colchicine, pronamide, dithipyr, trifluralin, or another known anti-microtubule agent. 6. The method of claim 1 , wherein the DNA modification enzyme is a site-directed nuclease selected from the group consisting of meganucleases (MNs), zinc-finger nucleases (ZFNs), transcription-activator like effector nucleases (TALENs), Cas9 nuclease, Cpf1 nuclease (Cas12a), dCas9-FokI, dCpf1-FokI, chimeric Cas9-cytidine deaminase, chimeric Cas9-adenine deaminase, chimeric FEN1-FokI, and Mega-TALs, a nickase Cas9 (nCas9), chimeric dCas9 non-FokI nuclease, dCpf1 non-FokI nuclease, chimeric Cpf1-cytidine deaminase, and Cpf1-adenine deaminase. 7. The method of claim 1 , wherein the at least one guide nucleic acid is a guide RNA. 8. The method of claim 7 , wherein the guide RNA is an 18-21 nucleotide sequence and is at least 90% identical to a target sequence. 9. The method of claim 8 , wherein the target sequence is SEQ ID NO: 103, and wherein the dicot genomic DNA is Arabidopsis genomic DNA. 10. The method of claim 1 , wherein the first dicot plant expresses a marker gene. 11. The method of claim 10 , wherein the marker gene is selected from the group consisting of GUS, PMI, PAT, GFP, RFP, CFP, B1, C1, R-nj, anthocyanin pigments. 12. The method of claim 1 , wherein the first dicot plant is a transformable dicot plant selected and/or derived from the group consisting of Arabidopsis, Brassica , soybean, tomato, sunflower, and cotton. 13. The method of claim 1 , wherein the partial loss-of-function mutation is a frame-shift mutation near the 3′ terminus of the CENH3 gene. 14. The method of claim 1 , wherein the loss-of-function mutation is a knock-out mutation. 15. The method of claim 1 , wherein the at least one haploid progeny comprises SEQ ID NO: 104, 105, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, or 117, and further wherein the at least one haploid progeny is Arabidopsis.

Assignees

Inventors

Classifications

  • Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)} · CPC title

  • involving clustered regularly interspaced short palindromic repeats [CRISPR] · CPC title

  • Targeted insertion of genes into the plant genome by homologous recombination · CPC title

  • using markers (enzymes used as markers C12N15/52) · CPC title

  • Mutagenizing nucleic acids · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10519456B2 cover?
The presently disclosed subject matter relates to using a haploid inducing line (whether existing or created) and transforming the haploid line so that it encodes cellular machinery capable of editing genes. The transformed haploid inducing line is used as a parent in a cross between two plants. During pollination, the parental gametes fuse to form an embryo; and the gene editing machinery is a…
Who is the assignee on this patent?
Syngenta Participations Ag
What technology area does this patent fall under?
Primary CPC classification C12N15/8213. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 5 related publications on this page (citations in our corpus or others sharing the same primary CPC).